Antipsychotic safe, effective for resistant depression in phase 3 trial

Press/Media

Period	26 May 2022

Media coverage

Title	Antipsychotic safe, effective for resistant depression in phase 3 trial
Media name/outlet	Clinician Reviews
Country/Territory	United States
Date	26/05/22
URL	https://www.mdedge.com/content/antipsychotic-safe-effective-resistant-depression-phase-3-trial
Persons	James Murrough